Damatte E, Galmier M J, Lartigue-Mattei C, Pognat J F, Busch N, Chabard J L
Laboratoire de Chimie Analytique et de Spectrométrie de Masse, Faculté de Pharmacie de Clermont-Ferrand, France.
Eur J Drug Metab Pharmacokinet. 1996 Oct-Dec;21(4):315-25. doi: 10.1007/BF03189733.
The biotransformation of several analogs of the anti-calcium agent bepridil was studied comparatively in liver cells isolated from one rat. Three types of metabolites were identified by mass spectrometry, resulting from three phase I reactions: hydroxylation, N-debenzylation and pyrrolidine ring opening. The amount of each bepridil analog untransformed after 18 h of incubation depended on its liver toxicity rather than on its concentration in the culture medium. The proportion of phase I metabolites identified remained constant regardless of toxicity. The difference delta c (in %) between the initial concentration of the analog tested and the sum of the concentrations of untransformed material and of identified metabolites decreased with the increasing hepatocyte toxicity. The analogs tested were responsible for the liver toxicity. The presence of substituents in different positions on the N-phenyl moiety increased liver toxicity; ortho-substituted analogs were more toxic than para- or meta-substituted ones.
在从一只大鼠分离出的肝细胞中,对抗钙药物苄普地尔的几种类似物的生物转化进行了比较研究。通过质谱鉴定出了三种代谢产物,它们是由三种I相反应产生的:羟基化、N-去苄基化和吡咯烷环开环。孵育18小时后未转化的每种苄普地尔类似物的量取决于其肝脏毒性,而非其在培养基中的浓度。无论毒性如何,鉴定出的I相代谢产物的比例保持恒定。所测试类似物的初始浓度与未转化物质和已鉴定代谢产物浓度之和之间的差异δc(百分比)随着肝细胞毒性的增加而降低。所测试的类似物导致了肝脏毒性。N-苯基部分不同位置上取代基的存在增加了肝脏毒性;邻位取代的类似物比对位或间位取代的类似物毒性更大。